Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline-Reference-Cited by-同舟云学术

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

Published:2023-11-06 Issue:1 Volume:204 Page:127-135
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

McLornan Donal P.¹^ORCID,Godfrey Anna L.²,Green Anna³,Frewin Rebecca⁴,Arami Siamak⁵,Brady Jessica⁶,Butt Nauman M.⁷,Cargo Catherine⁸,Ewing Joanne⁹,Francis Sebastian¹⁰,Garg Mamta¹¹,Harrison Claire¹²^ORCID,Innes Andrew¹³^ORCID,Khan Alesia⁸,Knapper Steve¹⁴,Lambert Jonathan¹,Mead Adam¹⁵¹⁶^ORCID,McGregor Andrew¹⁷,Neelakantan Pratap¹⁸,Psaila Bethan¹⁵¹⁶^ORCID,Somervaille Tim C. P.¹⁹,Woodley Claire¹²,Nangalia Jyoti²⁰,Cross Nicholas C. P.²¹^ORCID,McMullin Mary Frances²²^ORCID,

Affiliation:

1. Department of Haematology University College London Hospitals London UK

2. Haematopathology and Oncology Diagnostics Service, Department of Haematology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

3. Department of Histopathology Guy's and St. Thomas' NHS Foundation Trust London UK

4. Department of Haematology Gloucestershire Hospitals NHS Foundation Trust Gloucester UK

5. Department of Haematology London Northwest Healthcare University NHS Trust London UK

6. Department of Clinical Oncology Guy's and St. Thomas' NHS Foundation Trust London UK

7. Department of Haematology The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool UK

8. Department of Haematology Leeds Teaching Hospitals NHS Foundation Trust Leeds UK

9. Department of Haematology University Hospitals Birmingham Trust Birmingham UK

10. Department of Haematology Sheffield Teaching Hospital NHS Foundation Trust Sheffield UK

11. Department of Haematology University Hospitals Leicester NHS Trust Leicester UK

12. Department of Haematology Guy's and St. Thomas' NHS Foundation Trust London UK

13. Department of Haematology Imperial College London UK

14. Department of Haematology Cardiff University Cardiff UK

15. MRC Weatherall Institute of Molecular Medicine University of Oxford Oxford UK

16. Department of Haematology Churchill Hospital, Oxford University NHS Trust Oxford UK

17. Department of Haematology Freeman Hospital Newcastle upon Tyne UK

18. Department of Haematology Royal Berkshire NHS Foundation Trust Berkshire UK

19. Cancer Research UK Manchester Institute and The Christie NHS Foundation Trust Manchester UK

20. Wellcome Sanger Institute University of Cambridge Cambridge UK

21. Faculty of Medicine University of Southampton Southampton UK

22. Centre for Medical Education Queen's University Belfast UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19164

Reference53 articles.

1. Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

2. How common are myeloproliferative neoplasms? A systematic review and meta-analysis

3. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

4. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

5. Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score